| Amy R Wooldridge, MD | |
|
1 Memorial Sq Ste 305, Greenfield, IN 46140-3308 | |
| (317) 462-6662 | |
| (317) 468-6275 |
| Full Name | Amy R Wooldridge |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 1 Memorial Sq Ste 305, Greenfield, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386624070 | NPI | - | NPPES |
| 200311740H,L | Other | MEDICAID GROUP#/LOCATION | |
| 900284355 | Other | IN | MEDICARE RAILROAD # |
| 200486100 | Medicaid | IN | |
| 7482613 | Other | IN | AETNA PIN# |
| 000000364755 | Other | IN | ANTHEM PIN# |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suburban Home Health Llc | Noblesville, IN | Home health agency |
| Hancock Regional Hospital | Greenfield, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cora Health Services, Inc. | 1759290992 | 556 |
| Hancock Physician Network, Llc | 8325952633 | 107 |
| Hancock Regional Hospital | 1850205162 | 45 |
News Archive
An examination of the genetic landscape of head and neck cancers indicates that while metastatic and primary tumor cells share similar mutations, recurrent disease is associated with gene alterations that could be exquisitely sensitive to an existing cancer drug.
Ipsen, an innovation-driven global specialty pharmaceutical group, announced an agreement whereby Ipsen grants the Menarini Group the exclusive licence rights to Adenuric® (febuxostat) in 41 countries. Ipsen retains co-promotion rights for Adenuric® in France.
The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.
Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.
› Verified 9 days ago
| Entity Name | Hancock Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609806470 PECOS PAC ID: 8325952633 Enrollment ID: O20040130000777 |
News Archive
An examination of the genetic landscape of head and neck cancers indicates that while metastatic and primary tumor cells share similar mutations, recurrent disease is associated with gene alterations that could be exquisitely sensitive to an existing cancer drug.
Ipsen, an innovation-driven global specialty pharmaceutical group, announced an agreement whereby Ipsen grants the Menarini Group the exclusive licence rights to Adenuric® (febuxostat) in 41 countries. Ipsen retains co-promotion rights for Adenuric® in France.
The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.
Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.
› Verified 9 days ago
| Entity Name | Hancock Regional Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255418356 PECOS PAC ID: 1850205162 Enrollment ID: O20040401000258 |
News Archive
An examination of the genetic landscape of head and neck cancers indicates that while metastatic and primary tumor cells share similar mutations, recurrent disease is associated with gene alterations that could be exquisitely sensitive to an existing cancer drug.
Ipsen, an innovation-driven global specialty pharmaceutical group, announced an agreement whereby Ipsen grants the Menarini Group the exclusive licence rights to Adenuric® (febuxostat) in 41 countries. Ipsen retains co-promotion rights for Adenuric® in France.
The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.
Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy R Wooldridge, MD Po Box 129, Greenfield, IN 46140-0129 Ph: (317) 468-6270 | Amy R Wooldridge, MD 1 Memorial Sq Ste 305, Greenfield, IN 46140-3308 Ph: (317) 462-6662 |
News Archive
An examination of the genetic landscape of head and neck cancers indicates that while metastatic and primary tumor cells share similar mutations, recurrent disease is associated with gene alterations that could be exquisitely sensitive to an existing cancer drug.
Ipsen, an innovation-driven global specialty pharmaceutical group, announced an agreement whereby Ipsen grants the Menarini Group the exclusive licence rights to Adenuric® (febuxostat) in 41 countries. Ipsen retains co-promotion rights for Adenuric® in France.
The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.
Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.
› Verified 9 days ago
Kerri A. Kissell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Sq Ste 2200, Greenfield, IN 46140 Phone: 317-462-6662 Fax: 317-468-6275 | |
Thomas L Whittaker, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: One Memorial Sq, Ste 50, Greenfield, IN 46140 Phone: 317-467-7100 Fax: 317-467-0209 | |
Thomas Jay Failinger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E Boyd Ave Ste 201, Greenfield, IN 46140 Phone: 317-462-5112 | |
Charles R Taylor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E Boyd Ave Ste 201, Greenfield, IN 46140 Phone: 317-462-5112 Fax: 317-462-5122 | |
Dr. Stephen J. Flink, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 E Boyd Ave Ste 120, Greenfield, IN 46140 Phone: 317-462-3441 Fax: 317-477-6316 | |
Bryce S Lynn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E Boyd Ave Ste 201, Greenfield, IN 46140 Phone: 317-462-5112 | |
Drew Dust, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Sq Ste 2200, Greenfield, IN 46140 Phone: 317-462-6662 Fax: 317-468-6275 |